[First clinical trials of a new synthetic antidiabetic SB 1 or 1-(3-aminobenzenesulfonyl)-3-n-butylurea].
D005419:Flavonoids; D006801:Humans; D007004:Hypoglycemic Agents / Q000628:therapy*; D014508:Urea / Q000031:analogs & derivatives
D005419:Flavonoids; D007004:Hypoglycemic Agents; D014508:Urea; C047101:ganhuangenin; C006865:butylurea
ANTIDIABETICS/therapy